SEDIA BIOSCIENCES CORPORATION
ADVANCING ACCESS TO CARE THROUGH INNOVATION
Sedia Bioscience’s mission is to advance global access to healthcare by developing innovative disease surveillance and monitoring tools, expanding accessible point-of-care diagnostic testing into both technology-rich and resource-limited settings and providing cost-effective specimen collection devices.
Sedia Biosciences is a privately held Delaware-registered medical device and diagnostics company founded in 2009 and based in Beaverton, Oregon, USA. Our commitment is to become a leader in three areas intended to advance global access to care:
- state-of-the-art rapid point of care diagnostic assays
- novel epidemiological disease surveillance assays and other public health tools and
- innovative clinical specimen collection devices to improve and facilitate remote collection of specimens for follow-up testing.
OUR PRODUCTS & SERVICES
Innovative Technology To Fight Global Pandemics
Sedia is a leading developer of the newest generation of in vitro diagnostic tests. We are dedicated to advancing access to medical care by developing innovative diagnostic and monitoring products that enable more cost effective and expanded testing for infectious diseases and other conditions.
Want to know more or have any questions? Send us a message!